BERBERINE COMPLEXES WITH DNA IN THE BERBERINE-INDUCED APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS

被引:190
作者
KUO, CL
CHOU, CC
YUNG, BYM
机构
[1] NATL YANG MING MED COLL,GRAD INST PHARMACOL,TAIPEI,TAIWAN
[2] CHANG GUNG MED COLL,DEPT PHARMACOL,CANC BIOCHEM LAB,TAYUAN 333,TAIWAN
关键词
APOPTOSIS; BERBERINE-DNA COMPLEX;
D O I
10.1016/0304-3835(95)03809-B
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Berberine, an alkaloid initially isolated from Chinese herbal medicine exhibited the ability to induce morphological changes and internucleosomal DNA fragmentation, characteristic of apoptosis in promyelocytic leukemia HL-60 cells, Cell cycle studies showed that only about 20% of the cells underwent apoptosis at the early time (6 h) of berberine (25 mu g/ml) treatment; these appeared to be cells in S phase at the time of berberine treatment, At extended time (6-48 h), cells were cell cycle arrested, the number of cells of each phase, particularly the cells of S phase decreased and much more (> 50%) of the cells appeared with DNA content less than G(1). Attempts were also made to isolate possible berberine-DNA complexes from cell cultures treated with berberine (25 mu g/ml; 2-24 h). Shifts of absorption maxima of berberine in the direction of longer wavelengths were observed in the isolated berberine-DNA complexes. Palmatine, an analog of berberine, which was not able to induce apoptosis, also complexed with DNA in cells treated with palmatine (25 mu g/ml; 2-24 h), Our results suggest that some important cellular processes other than the intracellular DNA-interacting action of berberine may be involved in the berberine-induced apoptosis in HL-60 cells.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 26 条
[1]   BERBERINE-INDUCED MORPHOLOGICAL-DIFFERENTIATION AND DOWN-REGULATION OF C-KI-RAS2 PROTOONCOGENE EXPRESSION IN HUMAN TERATOCARCINOMA CELLS [J].
CHANG, KSS ;
GAO, C ;
WANG, LC .
CANCER LETTERS, 1990, 55 (02) :103-108
[2]   KEY MORPHOLOGICAL FEATURES OF APOPTOSIS MAY OCCUR IN THE ABSENCE OF INTERNUCLEOSOMAL DNA FRAGMENTATION [J].
COHEN, GM ;
SUN, XM ;
SNOWDEN, RT ;
DINSDALE, D ;
SKILLETER, DN .
BIOCHEMICAL JOURNAL, 1992, 286 :331-334
[3]  
DELBINO G, 1991, CANCER RES, V51, P1165
[4]  
DUVALL E, 1985, IMMUNOLOGY, V56, P351
[5]   DEATH AND THE CELL [J].
DUVALL, E ;
WYLLIE, AH .
IMMUNOLOGY TODAY, 1986, 7 (04) :115-119
[6]   LEISHMANIA-DONOVANI - AMASTIGOTE INHIBITION AND MODE OF ACTIOR OF BERBERINE [J].
GHOSH, AK ;
BHATTACHARYYA, FK ;
GHOSH, DK .
EXPERIMENTAL PARASITOLOGY, 1985, 60 (03) :404-413
[7]  
Hahn F.E., 1975, ANTIBIOTICS, V3
[8]  
HANO K, 1957, Gan, V48, P443
[9]  
HOSHI A, 1976, GANN, V67, P321
[10]  
HSU HY, 1982, TREATING CANCER CHIN